Literature DB >> 23880039

Preparation of porous bioceramics using reverse thermo-responsive hydrogels in combination with rhBMP-2 carriers: in vitro and in vivo evaluation.

Yin-Chih Fu1, Chung-Hwan Chen, Chau-Zen Wang, Yan-Hsiung Wang, Je-Ken Chang, Gwo-Jaw Wang, Mei-Ling Ho, Chih-Kuang Wang.   

Abstract

Porous biphasic calcium phosphates (BCP) were fabricated using reverse thermo-responsive hydrogels with hydroxyapatite (HAp) and β-tricalcium (β-TCP) powder and planetary centrifugal mixer. This hydrogel mixture slurry will shrink and compress the HAp powder during the sintering process. The porous bioceramics are expected to have good mechanical properties after sintering at 1200°C. Reverse thermo-responsive hydrogels of poly[(N-isopropylacrylamide)-co-(methacrylic acid)] p(NiPAAm-MAA) were synthesized by free-radical cross-linking copolymerization, and their chemical properties were evaluated by nuclear magnetic resonance spectroscopy, infrared spectroscopy, and electrospray-ionization mass spectrometry. The lower critical solution temperature (LCST) of the hydrogel was determined using turbidity measurements. A thermogravimetric analysis was used to examine the thermal properties. The porous bioceramic properties were analyzed by X-ray diffraction, scanning electron microscopy, bulk density, compressive strength testing and cytotoxicity. The compressive strength and average porosity of the porous bioceramics were examined at approximately 6.8MPa and 66% under 10wt% p(NiPAAm-MAA)=99:1 condition. The ratio of HAp/β-TCP can adjust two different compositional behaviors during the 1200°C sintering process without resulting in cell toxicity. The (rhBMP-2)-HAp-PLGA carriers were fabricated as in our previous study of the double emulsion and drop-coating technique. Results of animal study included histological micrographs of the 1-mm defect in the femurs, with the rhBMP-2 carrier group, the bioceramic spacer group and the bioceramic spacer with rhBMP-2 carriers group showing better callus formation around the femur defect site than the control group. The optimal dual effects of the bone growth factors from osteoconductive bioceramics and osteoinductive rhBMP-2 carriers produced better bone formation.
© 2013 The Authors. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bioceramics; Biphasic calcium phosphates; Non-union defect; Reverse thermo-responsive; RhBMP-2 carriers

Mesh:

Substances:

Year:  2013        PMID: 23880039     DOI: 10.1016/j.jmbbm.2013.06.009

Source DB:  PubMed          Journal:  J Mech Behav Biomed Mater        ISSN: 1878-0180


  5 in total

1.  Continuous release of bone morphogenetic protein-2 through nano-graphene oxide-based delivery influences the activation of the NF-κB signal transduction pathway.

Authors:  Cheng Zhong; Jun Feng; Xiangjin Lin; Qi Bao
Journal:  Int J Nanomedicine       Date:  2017-02-13

Review 2.  Bioactive Glass and Silicate-Based Ceramic Coatings on Metallic Implants: Open Challenge or Outdated Topic?

Authors:  Giulia Brunello; Hamada Elsayed; Lisa Biasetto
Journal:  Materials (Basel)       Date:  2019-09-10       Impact factor: 3.623

3.  Novel Osteogenic and Easily Handled Endodontic Calcium Silicate Cement Using Pluronic F127 Hydrogel.

Authors:  Jeong-Hyun Ryu; Jiyeon Roh; Utkarsh Mangal; Kwang-Mahn Kim; Sung-Hwan Choi; Jae-Sung Kwon
Journal:  Materials (Basel)       Date:  2022-10-06       Impact factor: 3.748

4.  Strengthening injectable thermo-sensitive NIPAAm-g-chitosan hydrogels using chemical cross-linking of disulfide bonds as scaffolds for tissue engineering.

Authors:  Shu-Wei Wu; Xifeng Liu; A Lee Miller; Yu-Shiuan Cheng; Ming-Long Yeh; Lichun Lu
Journal:  Carbohydr Polym       Date:  2018-03-17       Impact factor: 9.381

Review 5.  The Impact of Bioceramic Scaffolds on Bone Regeneration in Preclinical In Vivo Studies: A Systematic Review.

Authors:  Giulia Brunello; Sourav Panda; Lucia Schiavon; Stefano Sivolella; Lisa Biasetto; Massimo Del Fabbro
Journal:  Materials (Basel)       Date:  2020-03-25       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.